10x Genomics TXG 深 沪
等待开盘 07-07 09:30:00 美东时间
40.10
+1.090
+2.79%
华盛通- 最 高40.56
- 今 开38.86
- 成交量 79.43万股
- 最 低 37.93
- 昨 收 39.01
- 总市值 50.91亿
- 52周最高 40.56
- 市盈率 静 --
- 换手率 0.63%
- 52周最低 11.16
- 委 比 -67.54%
- 总股本 1.27亿
- 历史最高 208.99
- 量 比 0.32
- 振 幅 6.74%
- 历史最低 6.78
- 每 手 1
- 风险率 5.97%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅392.61%！Chardan Capital维持EyePoint"买入"评级，上调目标价至65美元
今日重点评级关注：Chardan Capital：维持EyePoint"买入"评级，目标价从29美元升至65美元；康托·菲茨杰拉德：维持Hyperliquid Strategies"超配"评级，目标价从8美元升至18.4美元
07-02 18:41
罗氏(RHHBY.US)推出Axelios基因测序仪 力图挑战Illumina(ILMN.US)市场主导地位
瑞士制药与诊断巨头罗氏(RHHBY.US)于本周一正式推出备受期待的Axelios基因测序仪，力图挑战美国公司Illumina(ILMN.US)在下一代基因测序...
06-29 18:52
Roche launches Axelios gene sequencer in a bid to loosen Illumina's grip
Roche launches Axelios gene sequencer in a bid to loosen Illumina's grip By Bhanvi Satija and Marleen Kaesebier LONDON/ZURICH, June 29 (Reuters) - Swiss pharma and diagnostics giant Roche ROG.S on Monday launched its long-awaited Axelios gene sequencer, in a bid to challenge U.S. firm Illumina's ILM
06-29 16:04
美股大行评级 | 瑞银上调超微公司目标价从455美元升至670美元，上调ARM目标价从260美元升至470美元；美银证券上调台积电目标价从490美元升至590美元
今日重点评级关注：Jones Trading：维持Definium Therapeutics"买入"评级，目标价从61美元升至74美元；韦德布什：维持Cerebras Systems"跑赢大市"评级，目标价从270美元升至280美元
06-25 11:32
Barclays Maintains Overweight on 10x Genomics, Raises Price Target to $40
Barclays analyst Luke Sergott maintains 10x Genomics (NASDAQ:TXG) with a Overweight and raises the price target from $30 to $40.
06-24 22:20
U.S. RESEARCH ROUNDUP-Bank of America, FedEx, JPMorgan
U.S. RESEARCH ROUNDUP-Bank of America, FedEx, JPMorgan June 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Bank of America, FedEx and JP Morgan on Wednesday. HIGHLIGHTS * Apogee Therapeutics APGE.O : Mizuho cuts to n
06-24 14:56
U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis
U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis June 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Datadog, Jabil and Prologis on Thursday. HIGHLIGHTS * Arthur J. Gallagher & Co. AJG.N : KBW raises target price to $
06-18 15:14
10x Genomics Partners With Cleveland Clinic Over Research In Novel Diagnostics For Bladder Cancer
10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced a research collaboration with Cleveland Clinic, a nonprofit multispecialty academic medical center that integrates clinical care with research and educatio...
06-17 21:04
10x Genomics buys Proteintech Genomics
10x Genomics (TXG) has acquired Proteintech Genomics, the genomics division of Proteintech Group, in a move aimed at expanding its proteomics capabilities. Financial terms of the deal were not disclos...
06-09 21:17
10x Genomics Acquires Proteintech Genomics; Financial Terms Undisclosed
10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced the acquisition of Proteintech Genomics, a division within Proteintech
06-09 21:07
